Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISI S.A. Earnings Release 2014

Feb 19, 2015

1484_10-k_2015-02-19_2aa07874-82a8-4d46-af4f-a01510154012.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Press release Belfort, February 19, 2015

LISI REPORTS INCREASE IN EARNINGS IN 2014 AND IS PREPARING FOR A NEW GROWTH CYCLE

  • Revenue: EUR 1.31 billion, up 13.7%
  • o Organic growth: +5.5%
  • o Contribution of Manoir Aerospace: +EUR 95 M revenue
  • Current operating margin maintained above 10%
  • Net profit up at EUR 81.4 M
  • Strong increase in Free Cash-Flow1 : EUR 45.6 M after EUR 91 M in net investments
  • Achievements in line with the divisions' business plan:
  • o LISI AEROSPACE, solid performance supported by markets which are still robust
  • o LISI AUTOMOTIVE, return to growth and improvement of profitability
  • o LISI MEDICAL, recovery confirmed
  • Dividend: EUR 0.37 per share
  • Solid prospects

February 19, 2015 – The Board of Directors of LISI, meeting under the chairmanship of Mr. Gilles Kohler, yesterday examined the final audited financial statements for the year ended on December 31, 2014. They will be submitted for approval to the General Meeting on April 22, 2015.

12 months ending December 31, 2014 2013 Change
Key elements of the income statement
Sales revenue EUR M 1,306.5 1,149.0 +13.7%
EBITDA EUR M 193.2 178.9 +8.0%
EBITDA margin % 14.8 15.6 - 0.8 pt
EBIT EUR M 131.7 128.9 +2.2%
Current operating margin % 10.1 11.2 - 1.1 pt
Earnings attributable to holders of company equity EUR M 81.4 74.6 +9.0%
Net earnings per share 1.55 1.421 +9.2%
Key elements of the cash flow statement
Operating cash flow EUR M 140.8 142.3 - 1.1 %
Net CAPEX EUR M - 90.6 - 87.7 +3.3%
Free Cash Flow2 EUR M 45.6 28.5 +60.0%
Key elements of the financial structure
Net debt EUR M 181.2 67.8 x 2.7
Ratio of net debt to equity 25.6% 10.8% +14.8 pts

1 Earnings per share restated after five-for-one stock split in 2014

2Free Cash Flow: operating cash flow minus net CAPEX and changes in working capital requirements.

Revenue: EUR 1,306.5 billion (up 13.7%), including organic growth of 5.5%

On a current exchange rate basis, all the divisions posted sales growth:

  • positive momentum continuing at LISI AEROSPACE (+18.7%), which is achieving historically high levels of sales, both in aeronautical fasteners and in structural components;
  • return to growth of LISI AUTOMOTIVE (+6.2% compared with 1.0% in 2013);
  • confirmed recovery of LISI MEDICAL (+10.8%, compared with -1.1% in 2013).

The +13.7% growth of in consolidated sales against 2013 also takes account of the consolidation, with effect from June 5, 2014 of the Manoir Aerospace group. Specializing mainly in the forging of metal parts for aeronautical applications, Manoir Aerospace adds strength to the Structural Components division of LISI AEROSPACE with complementary technologies. It contributed EUR 94.8 million to the Group's sales in 2014 (or 7.3%).

LISI of which Of which of which
Consolidated LISI AEROSPACE LISI AUTOMOTIVE LISI MEDICAL
Q1 EUR 311.3 M EUR 175.1 M EUR 117.8 M EUR 18.6 M
Q2 EUR 305.6 M EUR 172.7 M EUR 115.6 M EUR 17.5 M
Q3 EUR 339.2 M EUR 215.7 M EUR 107.4 M EUR 16.4 M
Q4 EUR 350.4 M EUR 224.5 M EUR 107.5 M EUR 18.6 M
2014 EUR 1,306.5 M EUR 788.1 M EUR 448.3 M EUR 71.1 M

At +6.3% in the second half year, following +4.8% in the first half, organic growth validates the commercial decisions taken by the Group's three divisions:

  • The growth of LISI AEROSPACE takes account of the integration of Manoir Aerospace, which represents 12% of the division's sales. Reported growth amounted to +37.1% in the second-half, and organic growth to +5.8%.
  • The last quarter for LISI AUTOMOTIVE showed marked progress: +6.2%, or +6.5% in the second half, compared with +5.9% for the first half.
  • The rate of growth in the sales of LISI MEDICAL increased significantly in the fourth quarter (+23.7%), or +10.9% in the second half, identical to that of the first half (+10.8%).

The share of the aerospace business in the Group's sales now amounts to nearly 60%. The automotive business represents 34% and LISI MEDICAL is unchanged at approximately 6% of consolidated sales.

Current operating margin maintained above 10%

The main management indicators are up. Hence, EBIT grew by +2.2% and amounted to EUR 131.7 M (compared with EUR 128.9 M in 2013). The decline in operating margin was contained to 1.1 points by reference to the previous year and is mainly explained by a dilution effect following the consolidation of the Manoir Aerospace group and by provisions related to reorganization measures taken by LISI AUTOMOTIVE. Operating margin amounted to 10.1% and is therefore in line with the Group's normative objectives of 10%.

Non-operating income fell very significantly to EUR -2.8 M, following the particularly high level in 2013 (- EUR 13.8 M).

The financial net income of - EUR 4.8 M comprises, on the one hand, the cost of financing for - EUR 4.6 M - namely an average cost of debt of 2% - up compared to 2013 due to the raising of credit lines following the acquisition of the Manoir Aerospace group and, on the other hand, the effect of currency fluctuations: they generated a year-on-year gain of + EUR 2.2 M, compared with a loss of - EUR 1.7 M in 2013.

The tax charge, calculated on the basis of the corporate income tax as a percentage of the net income before taxes, reflects an effective average rate of tax of 34.4%, slightly up compared with 2013 (33.2%).

At EUR 81.4 M, net income is up by +9.0% against 2013.

Net earnings per share amounted to EUR 1.55, compared with EUR 1.421 in 2013.

Based upon the results, the Group will propose at the Shareholders' General Meeting that the dividend be set at EUR 0.37 per share for the 2014 financial year.

The strength of the financial structure allows for significant capital expenditure

With a good level of cash flow at EUR 140.8 M, capital expenditure programs were easily financed, whilst at the same time producing an operating cash flow surplus ("Free Cash Flow") of EUR 45.6 M, sharply up in comparison with 2013 (EUR 28.5 M). Consolidated Working Capital Requirement was up, at 90 days (79 days in 2013) due in particular to the entry of the Manoir Aerospace group into the consolidation scope during the year.

LISI's financial structure made it possible to finance the acquisition of the Manoir Aerospace Group, while maintaining the strong ratios: after having reached a high point at June 30, 2014 at EUR 215.7 M, net financial debt fell in the second half to EUR 181.2 M at December 31st, representing 25.6% of shareholders' equity.

The return on capital employed, which amounted to 19.2% prior to the entry of the Manoir Aerospace Group, was 16.6% at the end of the year. Total capital employed increased in value by EUR 996 M (compared with EUR 776 M in 2013).

LISI AEROSPACE

  • Global commercial aerospace market still very solid
  • Consolidation of the Structural Components division with the integration of Manoir Aerospace
  • Significant increase in Free Cash Flow generation, despite capital expenditure maintained at a high level in order to absorb numerous new projects
2014 2013 Change
+4.3%
Sales revenue (in EUR M) 788.1 663.9 At constant scope and
exchange rates
Current operating margin 14.5% 17.8 % - 3.3 pts
Operating cash flow surplus
"Free Cash Flow" (EUR M)
43.9 32.6 + EUR 11.3 M
As a % of sales revenue 5.6% 4.9% + 0.7 pt

1 Earnings per share restated after five-for-one stock split in 2014

LISI AUTOMOTIVE

  • Gains in market share in a fairly dynamic environment
  • Turnaround in operating margin
  • Free Cash Flow penalized by restructuring plans and a significant capital expenditure program
2014 2013 Change
Sales revenue (in EUR M) 448.3 422.2 +6.4%
At constant scope and exchange
rates
Current operating margin 3.0% 2.7% + 0.3 pt
Operating cash flow surplus
"Free Cash Flow" (EUR M)
- 12.7 - 6.2 - EUR 6.5 M
As a % of sales revenue n.a. n.a. n.a.

LISI MEDICAL

  • Sharp increase in business at the end of the year
  • Improvement in profitability
  • Record order book
2014 2013 Change
Sales revenue (in EUR M) +10.8%
71.1 64.1 At constant scope and
exchange rates
Current operating margin 4.9% 4.0% + 0.9 pt
"Free Cash Flow" (EUR M) -1.0 -1.3 + EUR 0.3 M
As a % of sales revenue n.a. n.a. n.a.

OUTLOOK

2015 should be a year of further growth for the Group in the same way as 2014. The comparison with the previous year will benefit from the fact that Manoir Aerospace will be consolidated on a twelve month basis, instead of 6 months in 2014, while organic growth should reflect good performance from all the Group's markets.

While taking the major industrialization and reorganization projects in the Structural Components business into account, LISI is maintaining its objective of generating growth in all its management indicators expressed in absolute terms (EBITDA, EBIT, net income) and of producing a still very positive Free Cash Flow, while a capital expenditure plan of EUR 100 M will be dedicated to initiate a new phase of expansion, in optimal conditions of quality, productivity and financial independence.

Contact Emmanuel Viellard Phone: +33 (0)3 84 57 00 77 Email: [email protected] Website: www.lisi-group.com

The next announcements will appear after close of trading on Paris Euronext

Q1 2015 financial information: April 22, 2015 Shareholders' General Meeting: April 22, 2015 H1 2015 results: July 29, 2015 Q3 2015 financial Information: October 21, 2015

The LISI share is listed on NYSE Euronext, compartment B and belongs to the indices CAC®AERO& DEF., CAC® All Shares, CAC® – All Tradable, CAC® Industrials, CAC® Mid & Small, and CAC® Small, under ISIN code: FR 0000050353. LISI is a worldwide leading manufacturer of fasteners and assembly components for the Aerospace, Automotive, and medical implants industries.

Reuters Code:GFII.PA Bloomberg:FII FP

Reuters Code: GFII.PA Bloomberg: FII FP

LISI Group consolidated income

(in €'000) 31/12/2014 31/12/2013
Pre-tax sales 1 306 530 1 148 971
Changes in stock, finished products and production in progress 1 682 12 474
Total production 1 308 213 1 161 445
Other revenues 17 440 14 016
Total operating revenues 1 325 653 1 175 461
Consumed goods (344 613) (310 892)
Other purchases and external expenses (265 077) (219 416)
Value added 715 963 645 154
Taxes and duties (9 479) (8 614)
Personnel expenses (including temporary employees) (513 273) (457 657)
EBITDA 193 211 178 883
Depreciation
Net provisions
(64 630)
3 097
(57 450)
7 456
EBIT 131 678 128 889
Non-recurring operating expenses (10 852) (16 393)
Non-recurring operating revenues 8 058 2 639
Operating profit 128 883 115 134
Financing expenses and revenue on cash (6 410) (1 310)
Revenue on cash
Financing expenses
807
(7 217)
1 948
(3 258)
Other interest revenue and expenses 1 563 (2 504)
Other financial items 42 781 12 676
Other interest expenses (41 218) (15 180)
Taxes (of which CVAE (Tax on Companies' Added Value) (42 587) (36 779)
Share of net income of companies accounted for by the equity method 31
Profit (loss) for the period 81 479 74 540
attributable as company shareholders' equity 81 386 74 639
Interest not granting control over the company 93 (99)
Earnings per share (in €)* : 1,55 1,42
Diluted earnings per share (in €)* : 1,55 1,42

* Earnings per share restated after five-for-one stock split in 2014

STATEMENT OF OVERALL EARNINGS

(in €'000) 31/12/2014 31/12/2013
Profit (loss) for the period 81 479 74 540
Other items of overall income applied to shareholders equity
Actuarial gains and losses out of employee benefits (gross element) (6 248) 2 718
Actuarial gains and losses out of employee benefits (tax impact) 2 256 (609)
Restatements of treasury shares (gross element) (1) 388
Restatements of treasury shares (tax impact) 0 (140)
Payment in shares (gross element) 1 227 2 248
Payment in shares (tax impact) (443) (812)
Other items of overall income that will cause a reclassification of income
Exchange rate spreads resulting from foreign business 23 341 (9 702)
Hedging instruments (gross element) 239 (2 974)
Hedging instruments (tax impact) (86) 253
Impact of a correction in deferred taxation for previous periods on
share based payments and restatement of treasury stock (558)
Other portions of global earnings, after taxes 20 285 (9 187)
Total overall income for the period 101 764 65 353

LISI Group consolidated balance sheet

ASSETS

(in €'000) 31/12/2014 31/12/2013
LONG-TERM ASSETS
Goodwill 256 511 174 768
Other intangible assets 16 349 13 675
Tangible assets 431 847 371 208
Long-term financial assets 9 357 6 385
Deferred tax assets 22 992 11 066
Other long-term assets 976 936
Total long-term assets 738 034 578 038
SHORT-TERM ASSETS
Inventories 316 989 258 178
Taxes – Claim on the state 5 744 11 680
Trade and other receivables
Cash and cash equivalents
216 107
110 818
169 479
94 000
Total short-term assets 649 657 533 337

TOTAL EQUITY AND LIABILITIES

(in €'000) 31/12/2014 31/12/2013
SHAREHOLDERS' EQUITY
Capital stock
Additional paid-in capital
Treasury shars
Consolidated reserves
Conversion reserves
Other income and expenses recorded directly as shareholders' equity
Profit (loss) for the period
21 610
72 584
(15 042)
542 375
11 248
(6 505)
81 386
21 573
70 803
(14 135)
487 458
(12 078)
(3 084)
74 639
Total shareholders' equity - Group's share 707 657 625 179
Minority interests 1 117 1 253
Total shareholders' equity 708 777 626 434
LONG-TERM LIABILITIES
Long-term provisions
Long-term borrowings
Other long-term liabilities
Deferred tax liabilities
83 474
245 690
9 071
21 584
60 680
118 640
7 726
22 763
Total long-term liabilities 359 819 209 809
SHORT-TERM LIABILITIES
Short-term provisions
Short-term borrowings*
Trade and other accounts payable
Taxes due
22 907
46 363
244 261
5 566
21 060
43 178
207 627
3 626
Total short-term liabilities 319 096 275 131
TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES 1 387 691 1 111 375
* of which banking facilities 10 066 8 224

LISI Group consolidated cash flow table

(in €'000)
31/12/2014
31/12/2013
Operating activities
Net earnings 81 479 74 540
Elim. of the income of companies accounted for by the equity method
Elimination of net expenses not affecting cash flows:
(31)
- Depreciation and non-recurrent financial provisions 66 886 60 695
- Changes in deferred taxes (318) 793
- Income on disposals, provisions for liabilities and others
Gross cash flow margin
(4 490)
143 526
8 405
144 433
Net changes in provisions provided by or used for current operations (2 757) (2 099)
Operating cash flow 140 770 142 333
Income tax expense (revenue) 42 905 35 987
Elimination of net borrowing costs 4 837 2 824
Effect of changes in inventory on cash
Effect of changes in accounts receivable and accounts payable
(8 557)
(4 305)
(12 640)
(4 278)
Net cash provided by or used for operations before tax 175 649 164 227
Taxes paid (34 577) (45 206)
Cash provided by or used for operations (A) 141 072 119 019
Investment activities
Acquisition of consolidated companies (127 735)
Cash acquired 8 841
Acquisition of tangible and intangible fixed assets (92 548) (88 980)
Acquisition of financial assets
Change in granted loans and advances (215) (457)
Investment subsidies received
Dividends received
Total cash used for investment activities (211 657) (89 437)
Divested cash
Disposal of consolidated companies
Disposal of tangible and intangible fixed assets 1 923 1 319
Disposal of financial assets
Total cash from disposals
1 923 1 319
Cash provided by or used for investment activities (B) (209 733) (88 118)
Financing activities
Capital increase 1 838
Net disposal (acquisition) of treasury shares
Dividends paid to shareholders of the Group
Dividends paid to minority interests of consolidated companies
(17 820) (14 674)
Total cash from equity operations (15 982) (14 674)
Issue of long-term loans 155 307 5 137
Issue of short-term loans 467 72 269
Repayment of long-term loans
Repayment of short-term loans
(22 903) (4 663)
Net interest expense paid (33 105)
(4 837)
(87 170)
(2 826)
Total cash from operations on loans and other financial liabilities 94 928 (17 253)
Cash provided by or used for financing activities (C) 78 947 (31 926)
Effect of change in foreign exchange rates (D)
Effect of adjustments in treasury shares (D)
5 597
(908)
226
(4 691)
Changes in net cash (A+B+C+D) 14 975 (5 489)
Cash at January 1st (E) 85 776 91 269
Cash at year end (A+B+C+D+E) 100 751 85 776
Cash and cash equivalents
Short-term banking facilities
110 818
(10 066)
94 000
(8 224)
Closing cash position 100 751 85 776

Change in LISI Group consolidated shareholders' equity

(
in €
'00
0)
Ca
ital
p
sto
ck
Ca
ital
-lin
ked
p
pre
miu
ms
Tre
har
asu
ry s
s
Co
lida
ted
nso
res
erv
es
Co
rsio
n res
nve
erv
es
Oth
er i
nco
me
and
ex
pen
ses
ord
ed
rec
dire
ctly
as
sha
reh
old
'
ers
ity
equ
Pro
fit f
or t
he
iod
per
, gr
oup
sha
re
Gro
's s
har
f
up
e o
sha
reh
old
'
ers
ity
equ
Min
ori
ty
inte
ts
res
Tot
al
sha
reh
old
'
ers
ity
equ
Sha
reh
old
' eq
uity
at
Jan
y 1
, 20
13
ers
uar
21 5
73
70
803
(14
61
6)
445
58
8
(2 3
83)
(3 5
98)
57 2
87
574
65
7
1 36
0
576
01
7
Pro
fit (
los
s)
for
the
riod
N
(a
)
pe
Tra
nsl
atio
n d
iffe
tial
(
b)
ren
Pay
in
sha
(c
)
nts
me
res
Ca
ital
inc
p
rea
se
Res
of
har
(
d)
tate
nts
trea
me
sur
y s
es
Res
r IA
S19
(g
)
tate
nts
me
as
pe
Ap
iati
of N
-1 e
ing
pro
pr
on
arn
s
Ch
e in
ang
sc
ope
Div
ide
nds
dis
trib
d
ute
Re
cla
ssif
ica
tion
Res
of
fina
nci
al i
s (
f)
tate
nts
nst
ent
me
rum
Va
riou
0 0 481 57 2
87
0
(14
674
)
(9 6
95)
1 14
8
(22
)
2 1
09
-2 7
21
74 6
39
(57
287
)
74
639
-9 6
95
1 14
8
0
459
2 1
09
0
0
-14
67
4
0
-2 7
21
(99
)
(7)
0
0
0
74 5
40
-9 7
02
1 14
8
0
459
2 1
09
0
0
14 6
74
-
0
-2 7
21
s (e
)
Sha
reh
old
' eq
uity
at
Dec
ber
31
, 20
13
ers
em
21 5
73
70
803
(14
13
5)
(74
3)
487
45
8
(12
07
8)
(3 0
84)
74
639
-74
3
625
17
9
1 25
3
-74
3
626
43
4
inc
lud
ing
al r
d ex
d fo
tot
ste
eve
nue
s an
pen
ses
po
r
the
riod
(a)
(b)
+ (
c)
+ (d
) +
( e)
+ (
f) +
(g)
pe
+
(9 6
95)
514 74 6
39
65 4
58
(7)
(in €
)
'000
Cap
ital
sto
ck
Cap
ital-
link
ed
(No
miu
te
pre
ms
7.3)
Tre
har
asu
ry s
s
Con
ed rese
soli
dat
rves
Con
sion
ver
rese
rves
Oth
er i
and
nco
me
exp
ens
es
rde
d d
irec
tly
reco
har
eho
lder
s'
as s
Pro
fit fo
r th
e
iod,
per
gro
up
sha
re
Gro
up'
har
f
s s
e o
sha
reh
old
'
ers
ity
equ
Min
orit
y
inte
ts
res
Tot
al s
har
eho
lde
rs'
ity
equ
Sha
reh
old
' eq
uity
at
Jan
y 1
, 20
14
ers
uar
21 5
73
70
803
(14
13
4)
487
45
9
(12
07
8)
(3 0
83)
74
639
625
17
9
1 25
3
626
43
4
fit (
s)
(a
)
Pro
los
for
the
riod
N
pe
Tra
nsl
atio
n d
iffe
tial
(
b)
ren
Pay
in
sha
(c
)
nts
me
res
Ca
ital
inc
p
rea
se
of
(
d)
Res
tate
nts
trea
har
me
sur
y s
es
S19
Res
tate
nts
r IA
(g
)
me
as
pe
Ap
iati
of N
-1 e
ing
pro
pr
on
arn
s
Ch
e in
ang
sc
ope
Div
ide
nds
dis
trib
d
ute
ssif
Re
cla
ica
tion
Res
tate
nts
of
fina
nci
al i
nst
ent
s (
f)
me
rum
Va
riou
s (e
)
37 1 78
1
(90
8)
74
639
(
988
)
(17
)
820
(91
5)
23
327
784
(1)
(5 1
86)
981
81 3
86
(74
639
)
81
386
23
327
784
1 8
18
(
)
909
(
5 1
86)
0
(
988
)
(
17
820
)
0
981
(
)
915
93
14
0
(24
3)
0
81
479
23
341
784
1 8
18
(
)
909
(
5 1
86)
0
(
1 2
31)
(
)
17
820
0
981
(
)
915
Sh
ho
lde
rs'
ity
at D
mb
31,
20
14
are
equ
ece
er
inc
lud
ing
tal
and
d
to
ste
rev
enu
es
ex
pen
ses
po
for
eri
(a
) +
(
b)
+ (
c)
+ (
d) +
( e
) +
(
f)
th
od
e p
+ (g
)
21
610
584
72
(
15
)
042
542
5
37
11
248
23
327
(
6 5
05)
(
22)
3 4
81
386
81
386
65
707
7
101
29
1
1 1
17
14
708
77
7